Palvella Therapeutics PVLA
NASDAQ PVLA
$168.71 -5.37 (-3.08%)
At close: Nov 10, 2026 · 4:00 PM EST

Palvella Therapeutics (PVLA) Other Operating Expenses (2013 - 2023)

Updated

Palvella Therapeutics' Other Operating Expenses came in at -$14.89 million for Q4 2023.

Analysis

Palvella Therapeutics (PVLA) Other Operating Expenses (2013 - 2023) Analysis & Trends

For FY2023, Palvella Therapeutics' Other Operating Expenses was $23.1 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Palvella Therapeutics 2.47 Bn 2.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -13.91 Mn
Sep 30, 2014 18.00
Dec 31, 2013 36.00
Sep 30, 2013 12.00
API Access

Palvella Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=PVLA&period=max&api_key=YOUR_API_KEY